02312nam a2200421 i 4500001001300000003000600013005001700019007001400036008004100050040002800091042000800119043001200127050002300139074001900162088009000181086002300271099002300294110012900317245026400446264006000710300002700770336002600797337002700823338003100850500003600881500010800917504004101025500002601066500002501092533010701117650007301224650004501297650006101342655003301403776022601436776020901662999001901871on1001281899OCoLC20170911111918.0he bmb024bbca170816s2016    dcu     bb   f000 0 eng c  aGPObengerdacGPOdMvI  apcc  an-us---14aKF27b.E5546 2016b  a1019-B-01 (MF)  aSerial no. 114-173 (United States. Congress. House. Committee on Energy and Commerce)0 aY 4.C 73/8:114-173  aY 4.C 73/8:114-1731 aUnited States.bCongress.bHouse.bCommittee on Energy and Commerce.bSubcommittee on Oversight and Investigations,eauthor.10aBioresearch labs and inactivation of dangerous pathogens :bhearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, September 27, 2016. 1aWashington :bU.S. Government Publishing Office,c2016.  aiii, 99 pages ;c24 cm  atextbtxt2rdacontent  amicroformbh2rdamedia  amicrofichebhe2rdacarrier  aShipping list no.: 2017-0052-M.  aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.  aIncludes bibliographical references.  a"Serial no. 114-173."  aCRDP Program record.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2017]e2 microfiches : negative. 0aPathogenic microorganismsxHandlingzUnited StatesxSafety measures. 0aMicrobial inactivationxSafety measures. 0aBiological laboratorieszUnited StatesxSafety measures. 7aLegislative hearings.2lcgft08iPrint version:aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.tBioresearch labs and inactivation of dangerous pathogensw(DLC) 2017392623w(OCoLC)97247916608iOnline version:aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations.tBioresearch labs and inactivation of dangerous pathogensw(OCoLC)968934049  c266409d266409